Cresilon Killed Its Big Launch - Then Built a Bleeding-Control Business the Hard Way

A 17-year-old's algae experiment became a syringe of hemostatic gel. The useful business lesson came later, when blackened batches forced Cresilon to cancel a launch and become its own manufacturer.